Skip to content
easybpt
Browse topics

Clinical pharmacology

Assessing likelihood of an adverse drug reaction

How to judge whether a drug caused an adverse event, using the Naranjo scale (10 questions, score bands) with a worked example, the WHO-UMC categories, drug-specific tools (RUCAM, ALDEN), their limitations, and when to report to the TGA.

Tier 2Topic overview

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions7 flashcards

At a glance

  • Causality assessment asks how likely it is that this drug caused this event in this patient. It is separate from severity (how bad) and preventability.
  • The core clinical evidence is the same in every tool: timing, dechallenge (improvement on stopping), rechallenge (recurrence on re-exposure), alternative causes, previous reports, dose response and objective confirmation such as a drug level.
  • The Naranjo scale (1981) is the tool most often examined. The WHO-UMC system is the standard in pharmacovigilance. Event-specific tools exist for liver injury (RUCAM) and SJS/TEN (ALDEN).

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions7 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Turnstile bot check on sign-in and signed-out feedback

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.